By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911



Company News
Celldex (CLDX) Announces Departure Of Chief Medical Officer 9/13/2017 7:29:21 AM
Celldex (CLDX) Announces Completion Of Enrollment In Phase IIb Study Of Glembatumumab Vedotin In Triple Negative Breast Cancer 8/24/2017 6:35:23 AM
Celldex (CLDX) Reports Second Quarter 2017 Results 8/9/2017 1:53:47 PM
Celldex (CLDX) To Report Second Quarter 2017 Financial Results And Host Corporate Update Call 8/2/2017 1:11:39 PM
Celldex (CLDX) Announces Additions To The Board Of Directors And Senior Management Team 6/16/2017 8:16:36 AM
Celldex (CLDX) Presents Phase I Study Of Varlilumab And Opdivo At 2017 ASCO Annual Meeting 6/6/2017 10:43:25 AM
Celldex (CLDX) Presents Promising Overall Survival Data From Phase II Study Of Single-Agent Glembatumumab Vedotin In Patients With Checkpoint-Refractory Metastatic Melanoma 6/5/2017 11:07:34 AM
Celldex (CLDX) To Present Clinical Results At 2017 ASCO Annual Meeting 5/18/2017 12:27:38 PM
Celldex (CLDX) Reports First Quarter 2017 Results 5/10/2017 12:36:55 PM
Celldex (CLDX) Provides Corporate Update And Reports Full Year 2016 Results 3/15/2017 10:43:42 AM